In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Varian pays $185mm to buy interventional oncology companies Endocare and Alicon

Executive Summary

Varian Medical Systems Inc. is boosting its place in the interventional oncology market through a combined acquisition of two firms from the space. It will pay $185mm to buy Texas-based Endocare Inc. (a division of HealthTronics Inc.) and China-based Hangzhou Alicon Pharmaceutical Sci & Tec Co. Ltd.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash for Equity

Related Companies